Abstract
The pituitary gland and its peptide hormones continue to attract intense investigative interest. This review makes no pretense of including all clinical and research papers in the field. Difficulty is encountered in the classification of papers. Many papers dealing with the pituitary are better considered in sections dealing with the hypothalamus and others in sections dealing with regulation of the function of the various target hormones. Because prolactin and growth hormone do not act on endocrine target glands, they have received more attention. The newer developments in our knowledge of the somatomedins and other growth-hormone-dependent growth factors are reviewed in some detail. The subjects discussed in any review reflect the interests and prejudices of the author. Greater representation by articles from the Journal of Clinical Endocrinology and Metabolism reflects the personal association of the author with that journal.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mains, R.E., Eipper, B.A., and ling, N., 1977, Common precursor to corticotropins and endorphins, Proc. Natl. Acad. Sci. U.S.A. 74: 3014–3018.
Orth, D.N., and Nicholson, W.E., 1977, High molecular weight forms of human ACTH are glycoproteirts, J. Clin. Endocrinol. Metab. 44: 214–217.
Bachelot, I., Wolfsen, A.R., and Odell, W.D., 1977, Pituitary and plasma lipotropins: Demonstration of the artifactual nature of βMSH, J. Clin. Endocrinol. Metab. 44: 939–946.
Gilkes, J.J.H., Rees, L.H., and Besser, G.M., 1977, Plasma immunoreactive corticotrophin and lipotrophin in Cushing’s syndrome and Addison’s disease, B. Med. J. 1: 996–998.
Guillemin, R., Vargo, T., Rossier, J., Minick, S., ling, N., Rivier, C., Vale, W., and Bloom, F., 1977, β-Endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland, Science 197: 1367–1369.
Bertagna, X., Donnadieu, M., Idatte, J.-M., and Girard, F., 1977, Dynamics and characterization of plasma immunoreactive β-melanocyte stimulating hormone in hemodialysis patients: Its relationship to ACTH, J. Clin. Endocnnol. Metab. 45: 1179–1186.
Krieger, D.T., and Luria, M., 1977, Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in Cushing’s disease and Nelson’s syndrome, J. Clin. Endocrinol. Metab. 44: 361–368.
Matsukura, S., Kakita, T., Hirata, Y., Yoshimi, H., Fukase, M., Iwasaki, Y., Kato, Y., and Imura, H., 1977, Adenylate cyclase of GH and ACTH producing tumors of human: Activation by non-specific hormones and other bioactive substances, J. Clin. Endocrinol. Metab. 44: 392–397.
Fehm, H.L., Voigt, K.H., Land, R.E., Beinert, K.E., Kummer, G.W., and Pfeiffer, E.F., 1977, Paradoxical ACTH response to glucocorticoids in Cushing’s disease, N. Engl. J. Med. 297: 904–907.
Moore, T.J., Dluhy, R.G., Williams, G.H., and Cain, J.P., 1976, Nelson’s syndrome: Frequency, prognosis, and effect of prior pituitary irradiation, Ann. Intern. Med. 85: 731–734.
Hopwood, N.J., and Kenny, F.M., 1977, Incidence of Nelson’s syndrome after adrenalectomy for Cushing’s disease in children, Am. J. Dis. Child. 131: 1353–1356.
Jennings, A.S., Liddle, G.W., and Orth, D.N., 1977, Results of treating childhood Cushing’s disease with pituitary irradiation, N. Engl. J. Med. 297: 957–962.
Carmalt, M.H.B., Dalton, G.A., Fletcher, R.F., and Smith, W.T., 1977, The treatment of Cushing’s disease by trans-sphenoidal hypophysectomy, Q.J. Med. 46: 119–134.
Salassa, R.M., Laws, E.R., Carpenter, P.C., and Northcutt, R.C., 1978, Transsphenoidal removal of pituitary microadenoma in Cushing’s disease, Mayo Clin. Proc. 53: 24–28.
Gewirtz, G., and Yalow, R.S., 1974, Ectopic ACTH production in carcinoma of the lung, J. Clin. Invest. 53: 1022–1032.
Odell, W., Wolfsen, A., Yoshimoto, Y., Weitzman, R., Fisher, D., and Hirose, F., 1977, Ectopic peptide synthesis: A universal concomitant of neoplasia, Trans. Assoc. Am. Physicians 90: 204–227.
Bloomfield, G.A., Holdaway, I.M., Corrin, B., Ratcliffe, J.G., Rees, G.M., Ellison, M., and Rees, L.H., 1977, Lung tumours and ACTH production, Clin. Endocrinol. 6: 95–104.
Himsworth, R.L., Bloomfield, G.A., Coombes, R.C., Ellison, M., Gilkes, J.J.H., Lowry, P.J., Setchell, K.D.R., Slavin, G., and Rees, L.H., 1977, “Big ACTH” and calcitonin in an ectopic hormone secreting tumour of the liver, Clin. Endocrinol. 7: 45–61.
Krieger, D.T., and Gewirtz, G.P., 1974, The nature of the circadian periodicity and suppressibility of immunoreactive ACTH levels in Addison’s disease, J. Clin. Endocrinol. Metab. 39: 46–52.
Clayton, R., Schrieber, V., Burden, A.C., and Rosenthal, F.D., 1977, Secondary pituitary hyperplasia in Addison’s disease, Lancet 2: 954–956.
Desaulles, P.A., Riniker, B., and Rittel, W., 1969, High corticotrophic activity of a short chain synthetic corticotrophin analogue, in: Protein and Polypeptide Hormones (M. Margoulies, ed.), pp. 489–491, Excerpta Medica, Amsterdam.
Jeffcoate, W.J., Phenekos, C., Ratcliffe, J.G., Williams, S., Rees, L., and Besser, G.M., 1977, Comparison of the pharmacokinetics in man of two synthetic ACTH analogues: α1–24 and substituted α1–18 ACTH, Clin. Endocrinol. 7: 1–11.
Sandman, C.A., George J., McCanne, T.R., Nolan, J.D., Kaswan, J., and Kastin, A.J., 1977, MSH/ACTH 4–10 influences behavioral and physiological measures of attention, J. Clin. Endocrinol. Metab. 44: 884–891.
Mullin, B.R., Aloj, S.M., Fishman, P.H., Lee, G., Kohn, L.D., and Brady, R.O., 1976, Cholera toxin interactions with thyrotropin receptors on thyroid plasma membranes, Proc. Natl. Acad. Sci. U.S.A. 73: 1679–1683.
Mullin, B.R., Fishman, P.H., Lee, G., Aloj, S.M., Ledley, F.D., Winand, R.J., Kohn, L.D., and Brady, R.O., 1976, Thyrotropin-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors, Proc. Natl. Acad. Sci. U.S.A. 73: 842–846.
Mullin, B.R., Pacuszka, T., Lee, G., Kohn, L.D., Brady, R.O., and Fishman, P.H., 1978, Thyroid gangliosides with high affinity for thyrotropin: Potential role in thyroid regulation, Science 199: 77–79.
Ledley, F.D., Mullin, B.R., Lee, G., Aloj, S.M., Fishman, P.H., Hunt, L.T., Dayhoff, M.O., and Kohn, L.D., 1976, Sequence similarity between cholera toxin and glycoprotein hormones: Implications for structure activity relationship and mechanism of action, Biochem. Biophys. Res. Commun. 69: 852–859.
Erhardt, F.W., and Scriba, P.C., 1977, High molecular thyrotrophin (“big”-TSH) from human pituitaries: Preparation and partial characterization, Acta Endocrinol. 85: 698–712.
Larsen, P.R., and Frumess, R.D., 1977, Comparison of the biological effects of thyroxine and triiodothyronine in the rat, Endocrinology 100: 980–988.
Silva, J.E., and Larsen, P.R., 1977, Pituitary nuclear 3,5,3′-triiodothyronine and thyrotropin secretion: An explanation for the effect of thyroxine, Science 198: 617–620.
Carlson, H.E., and Brickman, A.S., 1977, Effect of hypocalcemia on hormonal responses to thyrotropin-releasing hormone, J. Clin. Endocrinol. Metab. 45: 209–214.
Croxson, M.S., Hall, T.D., Kletzky, O.A., Jaramillo, J.E., and Nicoloff, J.T., 1977, Decreased serum thyrotropin induced by fasting, J. Clin. Endocrinol. Metab. 45: 560–568.
Delitala, G., Rovasio, P., and Lotti, G., 1977, Suppression of thyrotropin (TSH) and prolactin (PRL) release by pyridoxine in chronic primary hypothyroidism, J. Clin. Endocrinol. Metab. 45: 1019–1022.
Samaan, N.A., Osborne, B.M., Mackay, B., Leavens, M.E., Duello, T.M., and Halmi, N.S., 1977, Endocrine and morphologic studies of pituitary adenomas secondary to primary hypothyroidism, J. Clin. Endocrinol. Metab. 45: 903–911.
Kourides, I.A., Ridgway, E.C., Weintraub, B.D., Bigos, S.T., Gershengorn, M.C., and Maloof, F., 1977, Thyrotropin-induced hyperthyroidism: Use of alpha and beta subunit levels to identify patients with pituitary tumors, J. Clin. Endocrinol. Metab. 45: 534–543.
Amir, S.M., Uchimura, H., and Ingbar, S.H., 1977, Interactions of bovine thyrotropin and preparations of human chorionic gonadotropin with bovine thyroid membranes, J. Clin. Endocrinol. Metab. 45: 280–292.
Boyd, A.E., III, and Sanchez-Franco, F., 1977, Changes in the prolactin response to thyrotropin-releasing hormone (TRH) during the menstrual cycle of normal women, J. Clin. Endocrinol. Metab. 44: 985–989.
Sowers, J.R., Carlson, H.E., Brautbar, N., and Hershman, J.M., 1977, Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man, J. Clin. Endocrinol. Metab. 44: 237–241.
Cooper, D.S., and Jacobs, L.S., 1977, Apomorpine inhibits the prolactin but not the TSH response to thyrotropin releasing hormone, J. Clin. Endocrinol. Metab. 44: 404–407.
Besses, G.S., Burrow, G.N., Spaulding, S.W., and Donabedian, R.K., 1975, Dopamine infusions acutely inhibit the TSH and prolactin response to TRH, J. Clin. Endocrinol. Metab. 41: 985–988.
Beitins, I.Z., Lipson, L.G., and McArthur, J.W., 1977, Immunoreactive luteinizing hormone, follicle stimulating hormone and their subunits in tissue culture media from normal and adenomatous, human pituitary fragments, J. Clin. Endocrinol. Metab. 45: 1271–1280.
Weintraub, B.D., Stannard, B.S., and Rosen, S.W., 1977, Combination of ectopic and standard human glycoprotein hormone alpha with beta sub-units: Discordance of immunologic and receptor-binding activity, Endocrinology 101: 225–235.
Prentice, L.G., and Ryan, R.J., 1975, LH and its subunits in human pituitary serum and urine, J. Clin. Endocrinol. Metab. 40: 303–312.
Reichert, L.E., Jr., and Ramsey, R.B., 1977, Evidence for the existence of a large molecular weight protein in human pituitary tissue having follicle stimulating hormone activity, J. Clin. Endocrinol. Metab. 44: 545–552.
Bahl, O.P., 1977, Human chorionic gonadotropin, its receptor and mechanism of action, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36: 2119–2127.
Beitins, I.Z., Derfel, R.L., O’Loughlin, K., and McArthur, J.W., 1977, Immunoreactive luteinizing hormone, follicle stimulating hormone and their subunits in human urine following gel filtration, J. Clin. Endocrinol. Metab. 44: 149–159.
Hoff, J.D., Lasley, B.L., Wang, C.F., and Yen, S.S.C., 1977, The two pools of pituitary gonadotropin: Regulation during the menstrual cycle, J. Clin. Endocnnol. Metab. 44: 302–312.
Jewelewicz, R., Dyrenfurth, I., Ferin, M., Bogumil, J., and Vande Wiele, R.L., 1977, Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle, J. Clin. Endocrinol. Metab. 45: 662–667.
Penny, R., Olambiwonnu, N.O., and Frasier, S.D., 1977, Episodic fluctuations of serum gonadotropins in pre-and post-pubertal girls and boys, J. Clin. Endocrinol. Metab. 45: 307–311.
Penny, R., Goldstein, I.P., and Frasier, S.D., 1977, Overnight gonadotropin secretion in normal females, J. Clin. Endocrinol. Metab. 44: 780–783.
Reiter, E.O., Root, A.W., and Duckett, G.E., 1977, LH and FSH levels in urine and serum of prepubertal and pubertal children receiving a 3 hour infusion of LH-RH, J. Clin. Endocrinol. Metab. 44: 56–61.
Santner, S.J., Kulin, H.E., and Santen, R.J., 1977, Usefulness of urinary gonadotropin measurements to assess luteinizing releasing factor (LRF) responsiveness in hypogonadotropic states, J. Clin. Endocrinol. Metab. 44: 313–321.
Lucky, A.W., Rebar, R.W., Blizzard, R.M., and Goren, E.M., 1977, Pubertal progression in the presence of elevated serum gonadotropins in girls with multiple endocrine deficiencies, J. Clin. Endocrinol. Metab. 45: 673–678.
Cunningham, G.R., and Huckins, C., 1977, An FSH and prolactin-secreting pituitary tumor: Pituitary dynamics and testicular histology, J. Clin. Endocnnol. Metab. 44: 248–253.
Demura, R., Kubo, O., Demura, H., and Shizume, K., 1977, FSH and LH secreting pituitary adenoma, J. Clin. Endocrinol. Metab. 45: 653–657.
Baker, B.L., and Yu, Y.-Y., 1977, An immunocytochemical study of human pituitary mammotropes from fetal life to old age, Am. J. Anat. 148: 217–240.
Vekemans, M., Delvoye, P., L’Hermite, M., and Robyn, C., 1977, Serum prolactin levels during the menstrual cycle, J. Clin. Endocrinol. Metab. 44: 989–993.
Rigg, L.A., and Yen, S.S.C., 1977, Multiphasic prolactin secretion during parturition in human subjects, Am. J. Obstet. Gynecol. 128: 215–218.
Woolf, P.D., Lee, L.A., Leebaw, W., Thompson, D., Iilavivathana, U., Brodows, R., and Campbell, R., 1977, Intracellular glucopenia causes prolactin release in man, J. Clin. Endocrinol. Metab. 45: 377–383.
Delvoye, P., Delogne-Desnoeck, J., Uwayitu-Nyampeta, and Robyn, C., 1977, Time-course of physiological hyperprolactinaemia during two years lactation, Clin. Endocrinol. 7: 257–259.
Franks, S., Nabarro, J.D.N., and Jacobs, H.S., 1977, Prevalence and presentation of hyperprolactinaemia in patients with “functioniess” pituitary tumors, Lancet 1: 778–780.
Baumann, G., Marynick, S.P., Winters, S.J., and Loriaux, D.L., 1977, The effect of osmotic stimuli on prolactin secretion and renal water excretion in normal man and in chronic hyperprolactinemia, J. Clin. Endocrinol. Metab. 44: 199–202.
Holland, O.B., Gomez-Sanchez, C.E., Kern, D.C., Weinberger, M.H., Kramer, N.J., and Higgins, J.R., 1977, Evidence against prolactin stimulation of aldosterone in normal human subjects and patients with primary aldosteronism, including a patient with a primary aldosteronism and a prolactin-producing pituitary microadenoma, J. Clin. Endocrinol. Metab. 45: 1064–1076.
Turkington, R.W., Majumder, G.C., Kadohama, N., MacIndoe, J.H., and Frantz, W.L., 1973, Hormonal regulation of gene expression in mammalian cells, Recent Prog. Horm. Res. 29: 417–455.
Witorsch, R.J., and Kitay, J.I., 1972, Pituitary hormones affecting adrenal 5α-reductase activity: ACTH, growth hormone and prolactin, Endocrinology 91: 764–769.
Forbes, A.P., Henneman, P.H., Griswold, G.C., and Albright, F., 1954, Syndrome characterized by galactorrhea, amenorrhea and low urinary FSH: Comparison with acromegaly and normal lactation, J. Clin. Endocrinol. Metab. 14: 265–271.
Varma, M.M., Huseman, C.A., Johanson, A.J., and Blizzard, R.M., 1977, Effect of prolactin on adrenocortical and gonadal function in normal men, J. Clin. Endocrinol. Metab. 44: 760–762.
Feldman, J.M., and Plonk, J.W., 1978, Effect of hyperprolactinemia on pituitary-adrenal function, Horm. Res. 9: 1–11.
Vermeulen, A., Suy, E., and Rubens, R., 1977, Effect of prolactin on plasma DHEA(S) levels, J. Clin. Endocrinol. Metab. 44: 1222–1225.
Bassi, F., Giusti, G., Borsi, L., Cattaneo, S., Giannotti, P., Forti, G., Pazzagli, M., Vigiani, C., and Serio, M., 1977, Plasma androgens in women with hyperprolactinaemic amenorrhoea, Clin. Endocrinol. 6: 5–10.
Carter, J.N., Tyson, J.E., Warne, G.L., McNeilly, A.S., Faiman, C., and Friesen, H.G., 1977, Adrenocortical function in hyperprolactinemic women, J. Clin. Endocrinol. Metab. 45: 973–980.
Parker, L.N., Sack, J., Fisher, D.A., and Odell, W D., 1978, The adrenarche: Prolactin, gonadotropins, adrenal androgens, and cortisol, J. Clin. Endocnnol Metab. 46: 396–401.
Wiebe, R.H., Handwerger, S., and Hammond, C.B., 1977, Failure of l-tryptophan to stimulate prolactin secretion in man, J. Clin. Endocrinol. Metab. 45: 1310–1312.
Lancranjan, I., Wirz-Justice, A., Puhringer, W., and Del Pozo, E., 1977, Effect of 1–5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man, J. Clin. Endocrinol. Metab. 45: 588–593.
Egge, A.C., Rogol, A.D., Varma, M.M., and Blizzard, R.M., 1977, Effect of cyproheptadine on TRH-stimulated prolactin and TSH release in man, J. Clin. Endocrinol. Metab. 44: 210–213.
Burrow, G.N., May, P.B., Spaulding, S.W., and Donabedian, R.K., 1977, TRH and dopamine interactions affecting pituitary hormone secretion, J. Clin. Endocrinol. Metab. 45: 65–72.
Fonzo, D., Angeli, A., Sivieri, R., Andriolo, S., Frajria, R., and Ceresa, F., 1977, Hyperprolactinemia in girls with idiopathic precocious puberty under prolonged treatment with cyproterone acetate, J. Clin. Endocrinol. Metab. 45: 164–168.
Morley, J.E., Dawson, M., Hodgkinson, H., and Kalk, W.J., 1977, Galactorrhea and hyperprolactinemia associated with chest wall injury, J. Clin. Endocrinol. Metab. 45: 931–935.
Ramirez, G., O’Neill, W.M., Jr., Bloomer, H.A., and Jubiz, W., 1977, Abnormalities in the regulation of prolactin in patients with chronic renal failure, J. Clin. Endocrinol. Metab. 45: 658–661.
Yamaji, T., Shimamoto, K., Kosaka, K., and Isurugi, K., 1977, Heterogeneity of prolactin and TSH response to TRH in hypogonadotropic hypogonadism, J. Clin. Endocrinol. Metab. 45: 319–323.
Spitz, I.M., Almaliach, U., Rosen, E., Polishuk, W., and Rabinowitz, D., 1977, Dissociation of prolactin responsiveness to TRH and chlorpromazine in women with isolated gonadotropin deficiency, J. Clin. Endocrinol. Metab. 45: 1173–1178.
Spitz, I.M., Landau, H., Almaliach, U., Rosen, E., Brautbar, N., and Russell, A., 1977, Diminished prolactin reserve: A case report, J. Clin. Endocrinol. Metab. 45: 412–418.
Onishi, T., Miyai, K., Aono, T., Shioji, T., Yamamoto, T., Okada, Y., and Kumahara, Y., 1977, Primary hypothyroidism and galactorrhea, Am. J. Med. 63: 373–378.
Healy, D.L., Pepperell, R.J., Stockdale, J., Bremner, W.J., and Burger, H.G., 1977, Pituitary autonomy in hyperprolactinemic secondary amenorrhea: Results of hypothalamic-pituitary testing, J. Clin. Endocrinol. Metab. 44: 809–819.
Seppälä, M., Lehtovirta, P., and Ranta, T., 1977, Discordant patterns of hyperprolactinaemia and galactorrhoea in secondary amenorrhoea, Acta Endocrinol. 86: 457–463.
Kletzky, O.A., Davajan, V., Mishell, D.R., Jr., Nicoloff, J., Mims, R., March, C.M., and Nakamura, R.M., 1977, A sequential pituitary stimulation test in normal subjects and in patients with amenorrhea-galactorrhea with pituitary tumors, J. Clin. Endocrinol. Metab. 45: 631–640.
Lachelin, G.C.L., Abu-Fadil, S., and Yen, S.S.C., 1977, Functional delineation of hyperprolactinemic-amenorrhea, J. Clin. Endocrinol. Metab. 44: 1163–1174.
Board, J.A., Fierro, R.J., Wasserman, A.J., and Bhatnagar, A.S., 1977, Effects of α-and β-adrenergic blocking agents on serum prolactin levels in women with hyperprolactinemia and galactorrhea, Am. J. Obstet. Gynecol. 127: 285–287.
Van Meter, Q.L., Gareis, F.J., Hayes, J.W., and Wilson, C.B., 1977, Galactorrhea in a 12-year-old boy with a chromophobe adenoma, J. Pediatr. 90: 756–759.
Koenig, M.P., Zuppinger, K., and Iiechti, B., 1977, Hyperprolactinemia as a cause of delayed puberty: Successful treatment with bromocriptine, J. Clin. Endocrinol. Metab. 45: 825–828.
Strauch, G., Valcke, J.C., Mahoudeau, J.A., and Bricaire, H., 1977, Hormonal changes induced by bromocriptine (CB-154) at the early stage of treatment, J. Clin. Endocrinol. Metab. 44: 588–590.
Lamberts, S.W.J., Seldenrath, H.J., Kwa, H.G., and Birkenhager, J.C., 1977, Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine, J. Clin. Endocrinol. Metab. 44: 180–184.
Foukas, M.D., 1973, An antilactogenic effect of pyridoxine, J. Obstet. Gynaecol. Br. Commonw. 80: 718–720.
McIntosh, E.N., 1976, Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vitamin B6), J. Clin. Endocrinol. Metab. 42: 1192–1195.
Tolis, G., Laliberte, R., Guyda, H., and Naftolin, F., 1977, Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes, J. Clin. Endocrinol. Metab. 44: 1197–1199.
Seeburg, P.R., Shine, J., Martial, J., Baxter, J.D., and Goodman, H.M., 1978, Structure and purification of human growth hormone (hGH) gene sequences, Clin. Res. 26: 427A.
Bieler, E.U., Pitout, M.J., Stroud, S.W., and van Rooyen, R.J., 1977, Conversion of monomeric human growth hormone and big growth hormone into different molecular weight forms in vitro and after injection into humans, Horm. Res. 8: 29–36.
Heymsfield, S.B., Bethel, R.A., Hall, E.C., Mills, J.B., Moseley, M.H., Kostyo, J.L., and Rudman, D., 1977, Anabolic actions of reduced and S-carbamidomethylated human growth hormone and its plasmin digest in man, J. Clin. Invest. 60: 563–570.
Moore, W.V., and Leppert, P., 1977, Binding of native and reduced carbamidomethylated hGH to rabbit liver plasma membranes, J. Clin. Endocrinol. Metab. 45: 569–575.
Lesniak, M.A., Gorden, P., and Roth, J., 1977, Reactivity of non-primate growth hormones and prolactins with human growth hormone receptors on cultured human lymphocytes, J. Clin. Endocrinol. Metab. 44: 838–849.
Carr, D., and Friesen, H.G., 1976, Growth hormone and insulin binding to human liver, J. Clin. Endocrinol. Metab. 42: 484–493.
Golde, D.W., Bersch, N., and Li, C.H., 1977, Growth hormone: Species-specific Stimulation of erythropoiesis in vitro, Science 196: 1112–1113.
Ledet, T., 1976, Growth hormone stimulating the growth of arterial medial cells in vitro: Absence of effect of insulin, Diabetes 25: 1011–1017.
Merimee, T.J., and Pulkkinen, A.J., 1977, GH-estrogen interaction in modulating insulin secretion, J. Clin. Endocrinol. Metab. 45: 232–235.
Heymsfield, S.B., Bethel, R.A., and Rudman, D., 1977, Hyperresponsiveness of patients with clinical and premyopathic myotonic dystrophy to human growth hormone, J. Clin. Endocrinol. Metab. 45: 147–158.
Aloia, J.F., Zanzi, I., Vaswani, A., Ellis, K., and Cohn, S.H., 1977, Combination therapy for osteoporosis, Metabolism 26: 787–792.
Lancranjan, I., and Marbach, P., 1977, New evidence for growth hormone modulation by the α-adrenergic system in man, Metabolism 26: 1225–1230.
LaRossa, J.T., Agrin, R., and Melby, J.C., 1977, Apomorphine-stimulated growth hormone release, Am. J. Med. 63: 909–913.
Caraceni, T., Panerai, A.E., Parati, E.A., Cocchi, D., and Muller, E.E., 1977, Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington’s chorea, J. Clin. Endocrinol. Metab. 44: 870–875.
Delitala, G., Devilla, L., Bionda, S., and Franca, V., 1977, Suppression of human growth hormone secretion by cyproheptadine, Metabolism 26: 931–936.
Lal, S., Guyda, H., and Bikadoroff, S., 1977, Effect of methysergide and pimozide on apomorphine-induced growth hormone secretion in men, J. Clin. Endocrinol. Metab. 44: 766–770.
Miyabo, S., Asato, T., and Mizushima, N., 1977, Prolactin and growth hormone responses to psychological stress in normal and neurotic subjects, J. Clin. Endocrinol. Metab. 44: 947–951.
Tenore, A., Berman, W.F., Parks, J.S., and Bongiovanni, A.M., 1977, Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease, J. Clin. Endocrinol. Metab. 44: 622–628.
Collu, R., Leboeuf, G., Letarte, J., and Ducharme, J.-R., 1977, Increase in plasma growth hormone levels following thyrotropin-releasing hormone injection in children with primary hypothyroidism, J. Clin. Endocrinol. Metab. 44: 743–747.
Zanoboni, A., and Zanoboni-Muciaccia, W., 1977, Elevated basal growth hormone levels and growth hormone response to TRH in alcoholic patients with cirrhosis, J. Clin. Endocrinol. Metab. 45: 576–578.
Panerai, A.E., Salerno, F., Manneschi, M., Cocchi, D., and Muller, E.E., 1977, Growth hormone and prolactin responses to thyrotropin-releasing hormone in patients with severe liver disease, J. Clin. Endocrinol. Metab. 45: 134–140.
Blundell, T.L., Bedarkar, S., Rinderknecht, E., and Humbel, R.E., 1978, Insulin-like growth factor: A model for tertiary structure accounting for immunoreactivity and receptor binding, Proc. Natl. Acad. Sci. U.S.A. 75: 180–184.
Chochinov, R.H., Mariz, I.K., and Daughaday, W.H., 1977, Isolation of a somatomedin from plasma of rats bearing growth hormone secreting tumors, Endocrinology 100: 549–556.
Canalis, E.M., Hintz, R.L., Dietrich, J.W., Maina, D.M., and Raisz, L.G., 1977, Effect of somatomedin and growth hormone on bone collagen synthesis in vitro, Metabolism 26: 1079–1087.
Dehnel, J.M., and Hamblen, D.L., 1977, Influence of oxygen tension on somatomedin activity in vitro, J. Endocrinol. 72: 361–369.
Rechler, M.M., Podskalny, J.M., and Nissley, S.P., 1977, Characterization of the binding of multiplication-stimulating activity to a receptor for growth polypeptides in chick embryo fibroblasts, J. Biol. Chem. 252: 3898–3910.
Rechler, M.M., Nissley, S.P., Podskalny, J.M., Moses, A.C., and Fryklund, L., 1977, Identification of a receptor for somatomedin-like polypeptides in human fibroblasts, J. Clin. Endocrinol. Metab. 44: 820–831.
Hollenberg, M.D., and Fryklund, L., 1977, Insulin and somatomedin A and B: Comparison of biological activities in cultured human skin-derived fibroblasts, Life Sci. 21: 943–950.
Thorsson, A.V., and Hintz, R.L., 1977, Specific 125I-somatomedin receptor on circulating human mononuclear cells, Biochem. Biophys. Res. Commun. 74: 1566–1573.
Kaufmann, U., Zapf, J., Torretti, B., and Froesch, E.R., Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo, J. Clin. Endocrinol. Metab. 44: 160–166.
Hintz, R.L., and Liu, F., 1977, Demonstration of specific plasma protein binding sites for somatomedin, J. Clin. Endocrinol. Metab. 45: 988–995.
Chochinov, R.H., Mariz, I.K., Hajek, A.S., and Daughaday, W.H., 1977, Characterization of a protein in mid-term human amniotic fluid which reacts in the somatomedin-C radioreceptor assay, J. Clin. Endocrinol. Metab. 44: 902–908.
D’Ercole, J., Underwood, L.E., and Van Wyk, J.J., 1977, Serum somatomedin-C in hypopituitarism and in other disorders of growth, J. Pediatr. 90: 375–381.
Furlanetto, R.W., Underwood, L.E., Van Wyk, J.J., and D’Ercole, A.J., 1977, Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay, J. Clin. Invest. 60: 648–657.
Megyesi, K., Gorden, P., and Kahn, C.R., 1977, Lack of a simple relationship between endogenous growth hormone and NSILA-s related peptides, J. Clin. Endocrinol. Metab. 45: 330–338.
Hyodo, T., Megyesi, K., Kahn, C.R., McLean, J.P., and Friesen, H.G., 1977, Adrenocortical carcinoma and hypoglycemia: Evidence for production of nonsuppressible insulin-like activity by the tumor, J. Clin. Endocrinol. Metab. 44: 1175–1184.
Hoffenberg, R., Howell, A., Epstein, S., Pimstone, B.L., Fryklund, L., Hall, K., Schwalbe, S., and Rudd, B.T., 1977, Increasing growth with raised circulating somatomedin but normal immunoassayable growth hormone, Clin. Endocrinol. 6: 443–448.
Phillips, L.S., and Young, H.S., 1976, Nutrition and somatomedin. II. Serum somatomedin activity and cartilage growth activity in streptozotocin-diabetic rats, Diabetes 25: 516–527.
Cohen, M.P., Jasti, K., and Rye, D.L., 1977, Somatomedin in insulin-dependent diabetes mellitus, J. Clin. Endocrinol. Metab. 45: 236–239.
Takano, K., Hizuka, N., Shizume, K., Hayashi, N., Motoike, Y., and Obata, H., 1977, Serum somatomedin peptides measured by somatomedin A radioreceptor assay in chronic liver disease, J. Clin. Endocrinol. Metab. 45: 828–832.
Daughaday, W.H., 1977, Extreme gigantism, N. Engl. J. Med. 297: 1267–1269.
Strauch, G., Lego, A., Therain, F., and Bricaire, H., 1977, Reversible plasma and red blood cells volumes increases in acromegaly, Acta Endocrinol. 85: 465–478.
Daggett, P.R., and Nabarro, J.D.N., 1977, Measurement of the 4 hour integrated plasma concentration of growth hormone in assessing the response of acromegalic patients to treatment, Clin. Endocrinol. 7: 437–441.
Lawrence, A.M., Gordon, D.L., Hagen, T.C., and Schwartz, M.A., 1977, Hypothalamic hypopituitarism after pituitary apoplexy in acromegaly, Arch. Intern. Med. 137: 1134–1137.
Cryer, P.E., and Daughaday, W.H., 1977, Adrenergic modulation of growth hormone secretion in acromegaly: Alpha-and beta-adrenergic blockade produce qualitatively normal responses but no effect on L-dopa suppression, J. Clin. Endocrinol. Metab. 44: 977–979.
Camanni, F., Massara, F., Belforte, L., Rosatello, A., and Molinatti, G.M., 1977, Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects, J. Clin. Endocrinol. Metab. 44: 465–473.
Takahara, J., Yakushiji, W., Yamauchi, J., Miyoshi, M., Hosogi, H., and Ofuji, T., 1977, Transient appearance of a provocative growth hormone response to l-dopa following incomplete adenomectomy in an acromegalic patient, J. Clin. Endocrinol. Metab. 44: 599–602.
Nakagawa, K., and Obara, T., 1977, Failure of growth hormone-suppressing agents to affect TSH-releasing hormone-and LH-releasing hormone-induced growth hormone release in acromegaly, J. Clin. Endocrinol. Metab. 44: 189.
Ishibashi, M., Yamaji, T., and Kosaka, K., 1977, Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients, J. Clin. Endocrinol. Metab. 45: 275–279.
Cassar, J., Mashiter, K., and Joplin, G.F., 1977, Bromocriptine treatment of acromegaly, Metabolism 26: 539–546.
Belforte, L., Camanni, F., Chiodini, P.G., Liuzzi, A., Massara, F., Molinatti, G.M., Muller, E.E., and Silvestrini, F., 1977, Long-term treatment with 2-Br-α-ergocryptine in acromegaly, Acta Endocrinol. 85: 235–248.
Schwinn, G., Dirks, H., McIntosh, C., and Kobberling, J., 1977, Metabolic and clinical studies on patients with acromegaly treated with bromocriptine over 22 months, Eur. J. Clin. Invest. 7: 101–107.
Chihara, K., Kato, Y., Abe, H., Furumoto, M., Maeda, K., and Imura, H., 1977, Sleep-related growth hormone release following 2-bromo-α-ergocriptine treatment in acromegalic patients, J. Clin. Endocrinol. Metab. 44: 78–84.
Rona, R.J., and Tanner, J.M., 1977, Aetiology of idiopathic growth hormone deficiency in England and Wales, Arch. Dis. Child. 52: 197–208.
Howse, P.M., Rayner, P.H.W., Williams, J.W., Rudd, B.T., Bertrande, P.V., Thompson, C.R.S., and Jones, L.A., 1977, Nyctohemeral secretion of growth hormone in normal children of short stature and in children with hypopituitarism and intrauterine growth retardation, Clin. Endocrinol. 6: 347–359.
Schonberger, W., Grimm, W., and Ziegler, R., 1977, The effect of Nacom (l-dopa and l-carbidopa) on growth hormone secretion in 75 patients with short stature, Eur. J. Pediatr. 127: 15–19.
Preece, M.A., and Tanner, J.M., 1977, Results of intermittent treatment of growth hormone deficiency with human growth hormone, J. Clin. Endocrinol. Metab. 45: 169–170.
Frasier, S.D., Aceto, T., Jr., Hayles, A.B., and Mikity, V.G., 1977, Collaborative study of the effects of human growth hormone in growth hormone deficiency. IV. Treatment with low doses of human growth hormone based on body weight, J. Clin. Endocrinol. Metab. 44: 22–31.
Lee, H.B., and Faiman, C., 1977, Isolated thyrotropin deficiency due to a pituitary tumor, Can. Med. Assoc. J. 116: 520–521.
Weber, F.T., Donnelly, W.H., Jr., and Bejar, R.L., 1977, Hypopituitarism following extirpation of a pharyngeal pituitary, Am. J. Dis. Child. 131: 525–528.
Rudman, D., Fleischer, A.S., Kutner, M.H., and Raggio, J.F., 1977, Suprahypophyseal hypogonadism and hypothyroidism during prolonged coma after head trauma, J. Clin. Endocrinol. Metab. 45: 747–754.
Olson, L.D., and Winternitz, W.W., 1977, Hypopituitarism: A complication of diabetes, South. Med. J. 70: 411–413.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer Science+Business Media New York
About this chapter
Cite this chapter
Daughaday, W.H. (1979). Anterior Pituitary. In: Ingbar, S.H. (eds) Contemporary Endocrinology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-4857-4_2
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4857-4_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-4859-8
Online ISBN: 978-1-4757-4857-4
eBook Packages: Springer Book Archive